The largest database of trusted experimental protocols

Brdu primary antibody

Manufactured by Abcam
Sourced in United States

The BrdU primary antibody is a laboratory reagent used for the detection and quantification of cells undergoing DNA synthesis during the S-phase of the cell cycle. It binds specifically to the thymidine analog bromodeoxyuridine (BrdU), which is incorporated into newly synthesized DNA during cell division.

Automatically generated - may contain errors

9 protocols using brdu primary antibody

1

BrdU Incorporation Assay for Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
MG-63 and Saos-2 cells were seeded in 24-well plates. After 24 h, they were added with 10 μmol/L BrdU (Beyotime, Shanghai, China) during the logarithmic proliferation phase for 2 h. After denaturing the cells, BrdU primary antibody (ab8152, 1: 100, Abcam, Shanghai, China) was added and incubated for 2 h at room temperature. Next, with the addition of fluorescent secondary antibody, the cells underwent another 2-hour incubation at room temperature. Finally, we labeled the nucleus with 10 μmol/L Hoechst33342 (Beyotime, Shanghai, China) and took photographs using a fluorescent inverted microscope and performed statistical analysis.
+ Open protocol
+ Expand
2

Quantifying Cell Proliferation with BrdU

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to previous experimental methods [29 (link)], Cells plated 24-well plates were fixed in paraformaldehyde, BrdU primary antibody was incubated (Abcam, Cambridge, MA, USA) with cells overnight. Finally, nuclei were stained by DAPI, and followed by imaging to select the field of vision.
+ Open protocol
+ Expand
3

TBMS1 Cytotoxicity in Melanoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
2 × 104 melanoma cells per well were cultured in 24-well plates overnight in a 37°C incubator and then were treated with TBMS1 alone or combined with other drugs for another 48 h. DMSO was used as control. After 48 h, 10 μg/ml BrdU (Sigma Aldrich) was added into cells for 2 h and then fixed with 4% paraformaldehyde for 15 min. Then cells was treated with 2 M HCl for 30 min and then followed by 0.3% Triton X-100 treatment for 15 min. Subsequently, cells were blocked with 10% goat serum in the PBST buffer (ZSGB-Bio, Beijing, China). Cells were then incubated with BrdU primary antibody (Abcam, Cambridge, MA, United States) and next with secondary antibody (Life Sciences, New York, NY, United States). Before being observed by microscopy, cells were stained with Hoechst 33258 (Life Sciences). BrdU-positive melanoma cells in random fields were counted and calculated.
+ Open protocol
+ Expand
4

BrdU Incorporation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
1.5 × 103 cells/well cells were cultured in 96‐well dish in the medium with a final concentration of 10μM BrdU. After incubation for 3 h, cells were fixed by 4% paraformaldehyde (PFA) for 15 min, then washed by PBS solution and treated with 0.2 TrtonX‐100, after which they were further washed and treated with DNase (Tiangen, China) for 20 min at room temperature. Then washed the cells with PBS and added BrdU primary antibody (Abcam, Cambridge, MA, USA) and incubated the cells at 4°C for 12 h. After washing the cell with PBS, cells were incubated with secondary antibody for 60 min. Washed the cells with PBS and detected the BrdU positive cells by fluorescence microscope.
+ Open protocol
+ Expand
5

BrdU Incorporation Assay for Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A BrdU incorporation assay was used to measure the cell proliferation. H9c2 cells were seeded into a μ-Slide 8-well glass bottom plate at a total number of 7500 per well. After treatment, the cells were incubated with medium containing 10 μM BrdU (Sigma, USA) for 24 hours. Then, cells were fixed by 70% ethanol and incubated with 2 M HCl for 30 min at room temperature. 1% BSA was used for blocking, and the cells were incubated with a BrdU primary antibody (1 : 500, Abcam, UK) overnight and with a secondary antibody (1: 250) for 2 hours at room temperature. DAPI (Invitrogen, USA) was stained in the final step. A fluorescent image was detected using a confocal microscope equipped with a 63x oil immersion objective. Blue fluorescence represents DAPI staining, and red fluorescence represents BrdU. Images were analyzed by using the manufacturer's software. The percentage of positive cells was calculated by counting the double-stained cells and total cells (as a standard) in five randomized fields.
+ Open protocol
+ Expand
6

Quantifying Proliferation in CNV Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proliferation of vascular endothelial cells in CNV mice was assessed by immunofluorescence staining for 5-bromo-2-deoxyuridine (BrdU). At D0 and D7 after photocoagulation, the mice were given an intravitreous injection with ATN-161 (1 μL, 1 μg/μL) in one eye and PBS (1 μL) in the other eye. These mice were injected intraperitoneally with BrdU (Sigma, St. Louis, MO) 0.2 mg per gram body weight at D2, D5, D7, D10, D13, and D14 [23 (link),24 (link)]. Eyes were collected at D7 and D14 and fixed with 4% paraformaldehyde for 1 h and then cut into 10-μm-thick slices. After being washed and permeabilized in PBS-T (PBS containing 1% Triton X-100) for 30 min, these slices were placed in 2N HCl for 30 min at room temperature and then washed 3 times with PBS-T. Before incubated in the mixture of Alexa 488-conjugated anti-rat secondary antibody (Abcam) and Dylight 594 Griffona simplicifolia Lectin-B4 (Vector Laboratories), the slices were incubated in BrdU primary antibody (Abcam) overnight at 4°C. Prolong gold antifade reagent with DAPI (Invitrogen) was used to label nuclei. The choroidal membranes of the mice were carefully dissected and flat-mounted after performing the steps described above. The images were captured by fluorescence microscopy (Nikon).
+ Open protocol
+ Expand
7

BrdU Quantification of Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice at E10.0 of gestation were weighed and injected with 0.1 μg/g BrdU. Half an hour after injection, the mice were euthanized via cervical dislocation. Embryos were isolated immediately, fixed with 4% paraformaldehyde for 2 h at 4 °C and embedded in paraffin. BrdU was detected by treating tissue sections with 2 N HCl for 20 min at 37 °C and incubating BrdU primary antibody (Abcam, 1:100) overnight at 4 °C. After 3 washes for 2 min each in PBS, a corresponding HRP-conjugated secondary antibody (Zhongshan golden bridge) was applied for 30 min at RT. After 3 washes for 2 min each in PBS, sections were stained with TSA Plus Fluorescein Kit (Histova, NEON 5-color IHC Kit for FFPE, 1:100, 20–60 s). After all antigens were labeled, images were captured on an Akoya Vectra Polaris (PerkinElmer). The numbers of BrdU+ endothelial cells in each EP cluster were measured using ImageJ software from merged images.
+ Open protocol
+ Expand
8

Melanoma Cell Proliferation Assay by BrdU Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation was monitored by BrdU staining.61 2 × 104 melanoma cells in logarithmic phase were seeded in 24-well plates and then attached overnight in 37 °C incubator. demethylzeylasteral (5 μM) was then added to medium and changed to melanoma cells. DMSO was used as control. After 48 h, 10 μg/ml BrdU (Sigma Aldrich, USA) was added into cells for 2 h and then fixed with 4% paraformaldehyde for 15 min. After treating with 2 M HCL and then treating with 0.3% TritonX-100, cells were blocking with 10% goat serum (ZSGB-Bio, Beijing, China). Cells were then successively incubated with BrdU primary antibody (Abcam, Cambridge, MA, USA) and then with secondary antibody (Life, New York, NY, USA). Before observing by microscopy, cells were stained with Hochest (Life, New York, NY, USA). BrdU-positive cells in random fields were counted.
+ Open protocol
+ Expand
9

Cell Proliferation and BrdU Incorporation Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
CellTiter 96 ® . A Queous One Solution Cell Proliferation Assay kit (Promega Corporation, Madison, WI, USA) was used to perform the 3-( 4
MTS) assay by following the instruction. The record absorbance at 490 nm was detected by microplate reader. We performed the detection every 24 h during 3 days.
Bromodeoxyuridine (BrdU) incorporation assay. Cells were seeded in 96-wells (2x10 3 cells/well) in the culture medium with BrdU incubation. After 2 h, phosphate-buffered saline (PBS) solution with paraformaldehyde (PFA) (4%) was used to fix cells for 20 min. Cells were washed by PBS and treated by DNase for 20 min at room temperature. Then, BrdU primary antibody (Abcam, Cambridge, MA, USA) was added and incubated at 4˚C for 12 h. After washing by PBS, cells were incubated with secondary antibody at room temperature for 60 min. Cell nucleus were dyed by 4',6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich; Merck KGaA). BrdU-positive cells were counted by microscope.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!